All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Mixed bag of investors pile in for Algeta’s $120m CB

Algeta, a Nkr10.6bn ($174m) market capitalisation Norwegian company that develops novel cancer treatments, raised $120m from a convertible bond on Tuesday that drew a mix of hedge and long-only funds.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree